Article
Ambulatory BP and Weight Reduction as Predictors of GLP-1RA CV Benefit
2025-06-14
Abstract excerpt
<h4>Background</h4> GLP-1 receptor agonists (GLP-1RA) and dual GLP-1/GIP agonists reduce cardiovascular events in patients with type 2 diabetes and obesity. The extent to which these benefits are mediated by blood pressure (BP) reduction versus weight loss, especially in hypertensive patients, remains unclear. <h4>Methods</h4> We conducted a systematic review and meta-analysis of randomized controlled trials publi...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 2ce147a5-721d-52a6-8fd4-6a1e86f77209
- DOI
- 10.1101/2025.06.12.25329536
